These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Process technologies for purity enhancement of large discovery libraries. Pottorf RS; Player MR Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438 [TBL] [Abstract][Full Text] [Related]
4. A review of high throughput technology for the screening of natural products. Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498 [TBL] [Abstract][Full Text] [Related]
5. High-throughput characterization and quality control of small-molecule combinatorial libraries. Kenseth JR; Coldiron SJ Curr Opin Chem Biol; 2004 Aug; 8(4):418-23. PubMed ID: 15288253 [TBL] [Abstract][Full Text] [Related]
7. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. Langer T; Krovat EM Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670 [TBL] [Abstract][Full Text] [Related]
8. Virtual compound screening in drug discovery. Stumpfe D; Ripphausen P; Bajorath J Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679 [TBL] [Abstract][Full Text] [Related]
9. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
10. Exploring the chemogenomic knowledge space with annotated chemical libraries. Savchuk NP; Balakin KV; Tkachenko SE Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252 [TBL] [Abstract][Full Text] [Related]
11. Novel technologies for virtual screening. Lengauer T; Lemmen C; Rarey M; Zimmermann M Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803 [TBL] [Abstract][Full Text] [Related]
12. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics. Posner BA Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185 [TBL] [Abstract][Full Text] [Related]
14. Chemical database preparation for compound acquisition or virtual screening. Bologa CG; Olah MM; Oprea TI Methods Mol Biol; 2006; 316():375-88. PubMed ID: 16671410 [TBL] [Abstract][Full Text] [Related]
15. Pursuing the leadlikeness concept in pharmaceutical research. Hann MM; Oprea TI Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323 [TBL] [Abstract][Full Text] [Related]
16. How good is your screening library? Irwin JJ Curr Opin Chem Biol; 2006 Aug; 10(4):352-6. PubMed ID: 16797220 [TBL] [Abstract][Full Text] [Related]
17. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors. Mizutani MY; Itai A J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385 [TBL] [Abstract][Full Text] [Related]
18. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules. Edwards PJ Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197 [TBL] [Abstract][Full Text] [Related]
19. Drug discovery and natural products: end of an era or an endless frontier? Li JW; Vederas JC Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993 [TBL] [Abstract][Full Text] [Related]
20. OSIRIS, an entirely in-house developed drug discovery informatics system. Sander T; Freyss J; von Korff M; Reich JR; Rufener C J Chem Inf Model; 2009 Feb; 49(2):232-46. PubMed ID: 19434825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]